Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities: 2023-2024

Historic Total Non-Current Liabilities for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $15.2 million.

  • Camp4 Therapeutics' Total Non-Current Liabilities fell 39.55% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 39.55%. This contributed to the annual value of $15.2 million for FY2024, which is 8.27% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Total Non-Current Liabilities of $15.2 million as of FY2024, which was down 8.27% from $16.5 million recorded in FY2023.
  • Over the past 5 years, Camp4 Therapeutics' Total Non-Current Liabilities peaked at $16.5 million during FY2023, and registered a low of $15.2 million during FY2024.
  • Over the past 2 years, Camp4 Therapeutics' median Total Non-Current Liabilities value was $15.8 million (recorded in 2023), while the average stood at $15.8 million.
  • Data for Camp4 Therapeutics' Total Non-Current Liabilities shows a maximum YoY decreased of 8.27% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Camp4 Therapeutics' Total Non-Current Liabilities stood at $16.5 million in 2023, then dropped by 8.27% to $15.2 million in 2024.